David Miklos
David Miklos
Dirección de correo verificada de
Citado por
Citado por
Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma
SS Neelapu, FL Locke, NL Bartlett, LJ Lekakis, DB Miklos, CA Jacobson, ...
New England Journal of Medicine 377 (26), 2531-2544, 2017
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
FL Locke, A Ghobadi, CA Jacobson, DB Miklos, LJ Lekakis, OO Oluwole, ...
The lancet oncology 20 (1), 31-42, 2019
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies
DA Winer, S Winer, L Shen, PP Wadia, J Yantha, G Paltser, H Tsui, P Wu, ...
Nature medicine 17 (5), 610-617, 2011
KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma
M Wang, J Munoz, A Goy, FL Locke, CA Jacobson, BT Hill, ...
New England journal of medicine 382 (14), 1331-1342, 2020
Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing
SD Boyd, EL Marshall, JD Merker, JM Maniar, LN Zhang, B Sahaf, ...
Science translational medicine 1 (12), 12ra23-12ra23, 2009
Rituximab for steroid-refractory chronic graft-versus-host disease
C Cutler, D Miklos, HT Kim, N Treister, SB Woo, D Bienfang, LB Klickstein, ...
Blood 108 (2), 756-762, 2006
Antibody responses to HY minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission
DB Miklos, HT Kim, KH Miller, L Guo, E Zorn, SJ Lee, EP Hochberg, ...
Blood 105 (7), 2973-2978, 2005
Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium
LJ Nastoupil, MD Jain, L Feng, JY Spiegel, A Ghobadi, Y Lin, S Dahiya, ...
Journal of Clinical Oncology 38 (27), 3119, 2020
The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in …
KR Cooke, L Luznik, S Sarantopoulos, FT Hakim, M Jagasia, DH Fowler, ...
Biology of Blood and Marrow Transplantation 23 (2), 211-234, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
D Miklos, CS Cutler, M Arora, EK Waller, M Jagasia, I Pusic, ME Flowers, ...
Blood, The Journal of the American Society of Hematology 130 (21), 2243-2250, 2017
Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements
SD Boyd, BA Gaëta, KJ Jackson, AZ Fire, EL Marshall, JD Merker, ...
The Journal of Immunology 184 (12), 6986-6992, 2010
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ...
Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment
AC Logan, H Gao, C Wang, B Sahaf, CD Jones, EL Marshall, I Buño, ...
Proceedings of the National Academy of Sciences 108 (52), 21194-21199, 2011
Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma
FL Locke, DB Miklos, CA Jacobson, MA Perales, MJ Kersten, OO Oluwole, ...
New England Journal of Medicine 386 (7), 640-654, 2022
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
JH Antin, HT Kim, C Cutler, VT Ho, SJ Lee, DB Miklos, EP Hochberg, ...
Blood 102 (5), 1601-1605, 2003
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation
E Zorn, DB Miklos, BH Floyd, A Mattes-Ritz, L Guo, RJ Soiffer, JH Antin, ...
The Journal of experimental medicine 199 (8), 1133-1142, 2004
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus …
KR Schultz, DB Miklos, D Fowler, K Cooke, J Shizuru, E Zorn, E Holler, ...
Biology of Blood and Marrow Transplantation 12 (2), 126-137, 2006
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated …
HE Kohrt, BB Turnbull, K Heydari, JA Shizuru, GG Laport, DB Miklos, ...
Blood, The Journal of the American Society of Hematology 114 (5), 1099-1109, 2009
Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation
GG Laport, K Sheehan, J Baker, R Armstrong, RM Wong, R Lowsky, ...
Biology of Blood and Marrow Transplantation 17 (11), 1679-1687, 2011
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors
DB Miklos, HT Kim, E Zorn, EP Hochberg, L Guo, A Mattes-Ritz, S Viatte, ...
Blood 103 (1), 353-359, 2004
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20